Abstract
The After Breast Cancer Pooling Project was established to examine the role of physical activity, adiposity, dietary factors, supplement use, and quality of life (QOL) in breast cancer prognosis. This paper presents pooled and harmonized data on post-diagnosis lifestyle factors, clinical prognostic factors, and breast cancer outcomes from four prospective cohorts of breast cancer survivors (three US-based and one from Shanghai, China) for 18,314 invasive breast cancer cases diagnosed between 1976 and 2006. Most participants were diagnosed with stage I-II breast cancer (84.7%). About 60% of breast tumors were estrogen receptor (ER)+/progesterone receptor (PR)+; 21% were ER−/PR−. Among 8,118 participants with information on HER-2 tumor status, 74.8% were HER-2− and 18.5% were HER-2+. At 1–2 years post-diagnosis (on average), 17.9% of participants were obese (BMI ≥ 30 kg/m2), 32.6% were overweight (BMI 25–29 kg/m2), and 59.9% met the 2008 Physical Activity Guidelines for Americans (≥2.5 h per week of moderate activity). During follow-up (mean = 8.4 years), 3,736 deaths (2,614 from breast cancer) and 3,564 recurrences have been documented. After accounting for differences in year of diagnosis and timing of post-diagnosis enrollment, five-year overall survival estimates were similar across cohorts. This pooling project of 18,000 breast cancer survivors enables the evaluation of associations of post-diagnosis lifestyle factors, QOL, and breast cancer outcomes with an adequate sample size for investigation of heterogeneity by hormone receptor status and other clinical predictors. The project sets the stage for international collaborations for the investigation of modifiable predictors for breast cancer outcomes.
Similar content being viewed by others
References
Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB (2007) Diet and breast cancer: a review of the prospective observational studies. Cancer 109:2712–2749
Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr et al (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87:1234–1245
Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213–218
Friedenreich CM (2010) The role of physical activity in breast cancer etiology. Semin Oncol 37:297–302
Kushi LH, Kwan ML, Lee MM, Ambrosone CB (2007) Lifestyle factors and survival in women with breast cancer. J Nutr 137:236S–242S
Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B et al (2006) Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 56:323–353
Norman SA, Potashnik SL, Galantino ML, De Michele AM, House L, Localio AR (2007) Modifiable risk factors for breast cancer recurrence: what can we tell survivors? J Womens Health (Larchmt) 16:177–190
Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316
McTiernan A, Irwin M, VonGruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28:4074–4080
Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E (2009) Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 114:13–22
Wei EK, Wolin KY, Colditz GA (2010) Time course of risk factors in cancer etiology and progression. J Clin Oncol 28:4052–4057
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15
Carmichael AR, Daley AJ, Rea DW, Bowden SJ (2010) Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol 36:1139–1148
Ibrahim EM, Al-Homaidh A (2010) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. doi:10.1007/s12032-010-9536-x
Bertram LA, Stefanick ML, Saquib N, Natarajan L, Patterson RE, Bardwell W et al (2010) Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study. Cancer Causes Control 22:427–435
Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635
Chen XL, Lu W, Zheng W, Gu K, Chen Z, Zheng Y et al (2010) Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat 122:823–833
Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29:25–31
Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis PI (2007) The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 9:R44
Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363
Saquib N, Pierce JP, Saquib J, Flatt SW, Natarajan L, Bardwell WA et al (2011) Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology 20:252–259
Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA et al (2011) Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat 127:541–547
Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW et al (2011) Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast Cancer Res Treat 125:519–527
Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ (2009) Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology Study. Breast Cancer Res Treat 118:395–405
Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443
Kang X, Zhang Q, Wang S, Huang X, Jin S (2010) Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ 182:1857–1862
Fleischauer AT, Simonsen N, Arab L (2003) Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr Cancer 46:15–22
Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H et al (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 20:262–271
Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J et al (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10, 159 cases from 12 studies. PLoS Med 7:e1000279
Pierce JP, Faerber S, Wright FA, Rock CL, Newman V, Flatt SW et al (2002) A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women’s Healthy Eating and Living (WHEL) Study. Control Clin Trials 23:728–756
Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States). Cancer Cause Control 16:545–556
Colditz GA, Hankinson SE (2005) The Nurses’ Health Study: lifestyle and health among women. Nat Rev Cancer 5:388–396
Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W et al (2004) Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women’s Health Study. Eur J Clin Nutr 58:17–23
Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to Diet Questionnaire design and testing. Am J Epidemiol 124:453–469
Ritenbaugh C, Aickin M, Taren D, Teufel N, Graver E, Woolf K et al (1997) Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidem Biomar 6:347–354
Li L, Wang HM, Shen Y (2003) Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Commun Health 57:259–263
Li L, Wei H, Young D (1995) The development of the General Quality of life Inventory. China Ment Health J 9:227–231
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15:974–986
AJCC (2002) American Joint Committee on Cancer staging manual, 6th ed. Springer, New York
WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71–80
Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B et al (2008) Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Cause Control 19:1319–1328
Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L et al (2006) Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163:1053–1064
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Guarneri V, Barbieri E, Dieci MV, Piacentini F, Conte P (2010) Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer. Cancer Treat Rev 36(3):62–66
Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS et al (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117:409–416
USDHHS (2008) 2008 physical activity guidelines for Americans. USDHHS, Washington, DC
Gradishar WJ, O’Regan RM (2003) Progress in systemic adjuvant therapy of early-stage breast cancer. Int J Clin Oncol 8:239–247
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P et al (2010) Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172:10–20
Acknowledgments
The authors thank investigators and staff members of the research teams and study participants for their contributions and support for the study.
Financial support
This study was supported by the National Cancer Institute (Grant number 3R01CA118229-03S1). The parent grants for each individual cohort included in the After Breast Cancer Pooling Project are as follows: SBCSS (Department of Defense, DAMD 17-02-1-0607 and National Cancer Institute, R01 CA118229), WHEL (Susan G. Komen Foundation, #KG100988), LACE (National Cancer Institute, R01 CA129059), and NHS (P01 CA87969).
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nechuta, S.J., Caan, B.J., Chen, W.Y. et al. The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control 22, 1319–1331 (2011). https://doi.org/10.1007/s10552-011-9805-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9805-9